Palvella Therapeutics

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$20.20-$151.18
Market Cap
$1.7B
Shares Short
1M

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$0
Diluted EPS
-$4.17

News

See more

Yahoo Finance • 14 days ago

Roivant Sciences Ltd. (ROIV): One of the Best Stocks to Buy According to Joe Edelman

Yahoo Finance • 15 days ago

Eli Lilly and Company (LLY): One of the Top Low Risk High Growth Stocks?

Yahoo Finance • last month

Palvella Therapeutics Announces Scientific Publication in Journal of Vascular Anomalies Highlighting the Infiltrative Growth and Therapeutic Challenges of Microcystic Lymphatic Malformations

Yahoo Finance • 2 months ago

Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services

About

CEO
Mr. Wesley H. Kaupinen
CFO
Mr. Matthew E. Korenberg
Address
353 W. Lancaster Avenue, Wayne, PA, United States, 19087
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
29